Credit Suisse’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,308,600
| Closed | -$136M | – | 4143 |
|
|
2021
Q4 | $136M | Sell |
2,308,600
-675,400
| -23% | -$33.5M | 0.07% | 276 |
|
|
2021
Q3 | $128M | Buy |
2,984,000
+112,200
| +4% | +$4.97M | 0.07% | 283 |
|
|
2021
Q2 | $112M | Buy |
2,871,800
+788,100
| +38% | +$30.6M | 0.06% | 347 |
|
|
2021
Q1 | $75.5M | Buy |
2,083,700
+161,800
| +8% | +$5.74M | 0.04% | 540 |
|
|
2020
Q4 | $70.7M | Sell |
1,921,900
-970,592
| -34% | -$35.6M | 0.03% | 554 |
|
|
2020
Q3 | $101M | Buy |
2,892,492
+1,453,150
| +101% | +$50.9M | 0.06% | 342 |
|
|
2020
Q2 | $44.7M | Buy |
1,439,342
+461,757
| +47% | +$15.7M | 0.03% | 582 |
|
|
2020
Q1 | $30.3M | Buy |
977,585
+25,507
| +3% | +$869K | 0.03% | 641 |
|
|
2019
Q4 | $35.4M | Buy |
952,078
+86,955
| +10% | +$3.1M | 0.03% | 729 |
|
|
2019
Q3 | $29.5M | Sell |
865,123
-28,037
| -3% | -$1.02M | 0.02% | 702 |
|
|
2019
Q2 | $36.7M | Sell |
893,160
-235,147
| -21% | -$9.34M | 0.03% | 593 |
|
|
2019
Q1 | $45.5M | Buy |
1,128,307
+626,181
| +125% | +$25.1M | 0.04% | 457 |
|
|
2018
Q4 | $20.8M | Sell |
502,126
-23,715
| -5% | -$984K | 0.02% | 777 |
|
|
2018
Q3 | $22M | Sell |
525,841
-118,996
| -18% | -$4.58M | 0.02% | 820 |
|
|
2018
Q2 | $22.2M | Buy |
644,837
+216,281
| +50% | +$7.39M | 0.02% | 784 |
|
|
2018
Q1 | $14.4M | Sell |
428,556
-711,450
| -62% | -$24.5M | 0.01% | 1030 |
|
|
2017
Q4 | $39.2M | Buy |
1,140,006
+485,577
| +74% | +$16.6M | 0.04% | 529 |
|
|
2017
Q3 | $22.2M | Buy |
654,429
+106,349
| +19% | +$3.42M | 0.02% | 777 |
|
|
2017
Q2 | $17.5M | Buy |
548,080
+263,500
| +93% | +$8.31M | 0.02% | 878 |
|
|
2017
Q1 | $9.24M | Buy |
284,580
+52,911
| +23% | +$1.67M | 0.01% | 1267 |
|
|
2016
Q4 | $7.14M | Sell |
231,669
-26,350
| -10% | -$804K | 0.01% | 1410 |
|
|
2016
Q3 | $8.29M | Sell |
258,019
-451,534
| -64% | -$15.1M | 0.01% | 1321 |
|
|
2016
Q2 | $23.7M | Buy |
709,553
+149,668
| +27% | +$4.78M | 0.03% | 682 |
|
|
2016
Q1 | $15.7M | Sell |
559,885
-332,221
| -37% | -$9.49M | 0.02% | 845 |
|
|
2015
Q4 | $27.3M | Buy |
892,106
+740,541
| +489% | +$23.3M | 0.03% | 624 |
|
|
2015
Q3 | $4.52M | Buy |
151,565
+50,381
| +50% | +$1.62M | 0.01% | 1639 |
|
|
2015
Q2 | $3.22M | Sell |
101,184
-158,100
| -61% | -$5.15M | ﹤0.01% | 2145 |
|
|
2015
Q1 | $8.56M | Sell |
259,284
-8,010
| -3% | -$255K | 0.01% | 1296 |
|
|
2014
Q4 | $7.9M | Buy |
267,294
+85,163
| +47% | +$2.44M | 0.01% | 1434 |
|
|
2014
Q3 | $5.11M | Buy |
+182,131
| New | +$5.11M | ﹤0.01% | 1737 |
|
|
2014
Q2 | – | Sell |
-353,195
| Closed | -$10.8M | – | 4769 |
|
|
2014
Q1 | $10.8M | Buy |
353,195
+247,795
| +235% | +$7.39M | 0.01% | 1199 |
|
|
2013
Q4 | $3.06M | Buy |
+105,400
| New | +$3.07M | ﹤0.01% | 2277 |
|
|
2013
Q3 | – | Sell |
-790,500
| Closed | -$21M | – | 4327 |
|
|
2013
Q2 | $21M | Buy |
+790,500
| New | +$21.8M | 0.02% | 737 |
|
Other funds holding PFE
Credit Suisse's PFE Position: Q1 2024 in Review
Credit Suisse reduced its Pfizer (PFE) stake by 4% in Q1 2024, selling an estimated $10.1M and leaving 8,614,681 shares worth $239M. The position accounts for 0.23% of the portfolio, ranked #80.
Credit Suisse first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.39B in Q4 2014. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Credit Suisse held 8,614,681 shares of Pfizer worth $239M as of Q1 2024.
- Credit Suisse sold 363,142 Pfizer shares in Q1 2024, an estimated $10.1M.
- Pfizer made up 0.23% of Credit Suisse's portfolio in Q1 2024, its #80 holding.
- Credit Suisse first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Pfizer position peaked at $1.39B in Q4 2014.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.